Skip to content

News

Regular Exercise and Yoga Increase Quality of Life

Regular Exercise and Yoga Increase Quality of Life

09/25/2012 Research published in the Oct. 2012 Journal of Evidence-Based Complementary and Alternative Medicine showed that ovarian cancer survivors who “participated in both regular exercise and yoga had higher scores … Continued

Fertility Sparing Surgery Recommended by Study

Fertility Sparing Surgery Recommended by Study

A study of 240 patients with ovarian cancer concluded that young women with early stage disease be provided the option of fertility sparing surgery, rather than aggressive debulking. The study … Continued

USPSTF Recommends Against Routine Screening For Ovarian Cancer

USPSTF Recommends Against Routine Screening For Ovarian Cancer

09/11/2012 Confirming the position taken in draft guidelines released in April, the US Preventive Services Task Force (USPSTF) recommended that women do not routinely get screened for ovarian cancer if they … Continued

Advocate Report: Summer 2012

Advocate Report: Summer 2012

Advocate Report: Summer 2012 Susan Leighton Summer 2012 was filled with an abundance of advocacy opportunities including the American Association of Cancer Researchers (AACR) Survivor-Scientist Program, the Drug Information Association … Continued

Gene Plays Role in Ovarian Cancer Resistance

Gene Plays Role in Ovarian Cancer Resistance

08/23/2012 According to a new study published in Cancer Research, Australian researchers have identified a gene that plays a significant role in the development of high-grade serous ovarian cancer tumors … Continued

Using Nanoparticles to Shrink Tumors in Mice

Using Nanoparticles to Shrink Tumors in Mice

08/23/2012 Reported online last week in Science Translational Medicine, researchers at MIT and Harvard used nanoparticles to demonstrate the nanoparticles that target a protein called ID4 can reduce ovarian cancer … Continued

Dose Dense Therapy Appears Beneficial

Dose Dense Therapy Appears Beneficial

A study of 637 Japanese women with ovarian, fallopian or primary peritoneal cancer showed that dose dense chemotherapy provided a benefit. The standard of care arm provided chemotherapy every three … Continued

Taxane Therapy Does Not Affect Pregnancy

Taxane Therapy Does Not Affect Pregnancy

A small retrospective study of women receiving taxane therapy for breast or ovarian cancer while pregnancy showed no statistically significant outcomes in maternal or fetal health. Read the abstract here

When Less Is More – Editorial

When Less Is More – Editorial

The L.A. Times published an editorial July 29 summing up years of data showing that aggressively screening and treating people for cancer does not always benefit them. The editorial also … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.